Page 20 - IJB-2-2
P. 20

3D bioprinting technology for regenerative medicine applications

            ton, SC and 3D-Bioassembly Tool (BAB) developed    example, thermal inkjet  printers require bioinks of
            by  Scipero, Orlando  USA  have been developed to   lesser thermal conductivity to improve the cell viabil-
            construct 3D tissues/organs. Though BAB is still in its   ity [73] . Biocompatibility is another important facet of a
            infancy, this method can evolve as a promising solu-  biological construct aimed for regenerative medicine
            tion to create patient-specific tissue constructs for re-  applications [74] . Bioinks should be biocompatible and
            generative  medicine  applications [33,70,71] . However,   provide a favorable milieu to the cells. The degradation
            lack of scalability and problems with precise printing   profile of  the constructs should  be in  tune with the
            are the major drawbacks  of the  current robotic  bio-  regeneration of  new tissues [75]   and the  degradation
            printers. Recently, Advanced Solutions (Kentucky,   products of the constructs should not cause any adverse
            USA) has developed a six-axis robotic dispensing bi-  reactions. Most importantly, bioinks should provide
            oprinter that can efficiently handle curves and allows   mechanical support and structural support to the
            precise printing of the structures. The main advantage   growing cells to maintain 3D microenvironment. Bio-
            of this  method is its software,  TSIM (TSIM-Tissue   inks should have biomimetic properties to have a pos-
            Structure Information Modeling) that can perform an   itive influence on the cell adherence, proliferation and
            MRI scan of human tissue and convert it into a printa-  other functionalities [76] . An ideal bioink should  also
            ble 3D shape. Robotic bioprinters and tissue spheroid   possess tunable gelation properties and easy to make
            encapsulators are well developed commercially avail-  chemical modifications to improve the biological fun-
                                                                        [1]
            able OBL  components.  However, high-performance   ctionalities . These attributes are essential for an ideal
            perfusion  bioreactors are yet to be developed to  im-  bioprinting material/bioink. The following section will
            prove organ printing. The existing technological chal-  give detailed descriptions about bioink materials.
            lenge is to develop  a  complete and perfect  OBL  to
            print organs at a larger scale for regenerative medicine   5.1 Natural Polymers
            applications.                                        (1) Alginate
                                                                 Sodium alginate (alginate) is a raw material  ex-
            5. Bioinks for 3D printing                         tracted from brown seaweed. Alginate is a  polysac-

            The 3D printing technology was initially developed for   charide and anionic in nature. It is a linear block co-
            many non-biological applications that involve the use   polymer having M (β-D mannuronic acid monomers)
            of high temperature and toxic organic solvents. These   and G (α-L-guluronic acid blocks) domains. Alginate
            harsh conditions are not suitable for printing biological   structure has a mixture of M and G domains. G-blocks
            cells and other biomaterials. Hence, it is essential for   can form ionic  bonds when interacts with divalent
            printing to find suitable bioinks with desired functional   cations and  become gels in solutions. Biomimetic
            and  mechanical properties in order to come close  to   structure, suitable viscosity, gelation at ideal tempera-
            native tissue. Both natural polymers (such as collagen,   tures and high biocompatibility are some of the prop-
            gelatin, alginate, fibrin, hyaluronic acid and chitosan)   erties of alginate that  makes it suitable for bioprint-
            and synthetic polymers (such as  polyethylene  glycol   ing [77–81] . Cell-laden 3D alginate hydrogels were pre-
            (PEG), poly(L-lactic acid) (PLA) and poly(ε-caprolac-  pared using inkjet printing [81] . Although this hydrogel
            tone)(PCL)) are  predominantly used  as  bioinks. Ul-  provides biocompatibility and mechanical strength, it
            trashort peptides that can self-assemble into nanofibr-  lacks cell recognition motifs. Moreover, bioprinting
            ous structures have recently been proposed  as novel   alginate  constructs of  thick  tissues with well inter-
            bioinks and are attractive  candidates for bioprinting   connected pores is yet to be achieved.
            due to biocompatibility and processability [72] . This ne-  (2) Collagen and Gelatin
            wly developed bioink contains helical fiber structures   Collagen is a naturally occurring protein in tissues
            that  strongly  resemble collagen  fibers  in topography   which constitutes largely of amino acids such as hyd-
            and diameter [72] .                                roxyproline, proline, glycine and trace amounts of su-
               Printability is an important feature of an ideal bioink.   lfur containing amino acids and aromatic amino acids.
            During printing, the bioink should be accurately depo-  Hydroxyproline and proline maintain the tertiary stru-
            sited in the construct providing the desired temporal   cture of the collagen. Collagen is a major extracellular
            and spatial resolution. Bioinks should also enhance the   matrix (ECM) protein and controls all the cellular fate
            cell viability post-printing and must have desired phy-  processes [82] . It is used as a scaffold material for vari-
            sico-chemical properties to suit the printing needs. For   ous tissue engineering applications; however, its poor

            16                          International Journal of Bioprinting (2016)–Volume 2, Issue 2
   15   16   17   18   19   20   21   22   23   24   25